Decrease of cardiovascular risk in patients with type 2 diabetes: review of the common strategies and clinical studies
Military Medical Academy of S.M. Kirov, Saint-Petersburg, Russia Recent clinical trials about the cardiovascular safety of empagliflozin and liraglutide demonstrated a convincing lowering effect on mortality from cardiovascular causes among the patients with type 2 diabetes. These findings resulted...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/0938f70fe352468e937a00e32e7e3b3e |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|